The variability in outcome in systemic lupus, especially when complicated by clinically evident nephritis, has resulted in many attempts to identify those patients destined for a poor outcome. In part, this endeavour has been motivated by the desire to use more aggressive treatments in those having the poorest outlook. This approach has been at least partly responsible for the improvement in outlook for those with severe lupus nephritis, so that paradoxically the success of prediction has now resulted in a lack of differentiation in outcome between patients with different severities of lupus nep 'tis. Equally, the proportion of such patients going into renal fail.ur~-at least over the first decade of evolution-has diminished dramatically over the past quarter century, so that differences in outcome are more difficult to predict.
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In their paper in this issue of Lupus, Esdaile and his colleagues have asked several questions of importance: can experienced clinicians used to the care of patients with lupus nephritis predict outcome from clinical information alone, and could items of information contained in renal biopsies improve their accuracy of prediction? A secondary question was whether the clinicians agreed in their predictions.
For almost the first time, Esdaile and colleagues have used the deceptively simple method of actually giving data at presentation/renal biopsy, derived from a cohort of patients with lupus nephritis and a known outcome, to a panel of experienced and motivated clinicians. They then added information available for the renal biopsies to see whether the clinicians' predictions could be improved by the data in the biopsy, and also compared the clinicians' prognosis with one generated by a computer model. The group of patients studied received, by contemporary standards, relatively treatment: neither cyclophosphamide nor plasma exchange was used. The mortality (22/87 over 8 years) was rather so that treatment effects may have been less than in other series. *
The results strongly vindicate the clinical acumen of the clinicians: they were able to predict both shortand long-term renal function with some accuracy. The principal predictor selected by the clinicians was plasma creatinine concentration at presentation, followed by quantity of proteinuria, blood pressure and intensity of haematuria; only two of these criteria used by the clinicians emerged as predictive from the multiple regression analysis, and the addition of data on age and initial platelet count improved on the clinicians' performance.
Is renal biopsy, then, necessary in patients with lupus nephritis? For predicting short-term outcome, apparently not; however, the degree of tubulo-interstitial fibrosis was a valuable predictor of longer-term outcome -as it is in most forms of primary glomerulonephritis. The important question of how the biopsy appearances might determine subsequent therapy was not addressed in this study, and becomes very difficult to analyse.
Finally, it is interesting that all four of the clinicians asked to evaluate these data included hypertension as one of their predictive factors. In fact, until the recent appearance of data on almost 700 patients with lupus from the GISNEL study', there had been no convincing data that hypertension adversely affected outcome in lupus nephritis, although it is a major clinical determinant of outcome in primary forms of nephritis. It did not figure in the multiple regression analysis in Esdaile's data. Similar analyses could be done for decision points later in the course of lupus nephritis, including evaluation of repeat renal biopsies. However, here, as at onset, we are in danger, by our very success in modifying treatment and improving outcome, of destroying our ability to see how this might have been achieved.
